Glucosamine 6-sulfate (GlcN6S) is a glucosamine derivative exhibiting anti-inflammatory effects in experimental autoimmune encephalomyelitis (EAE). It inhibits gene expression of IL-12, T-bet, and IFN-gamma, suppresses Th1 CD4 T cell differentiation, and may be utilised in multiple sclerosis (MS) research.